KEY FEATURES
| Full Name | Dopachrome Tautomerase |
|---|---|
| Synonym | TYRP2; TRP-2; DT; Dopachrome Delta-Isomerase; Tyrosine-Related Protein 2; L-dopachrome Delta-isomerase |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.13ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human DCT in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human DCT. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human DCT and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human DCT, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human DCT. You can calculate the concentration of Human DCT in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human DCT ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.94 | 2.43 | 8.78 | 0.9 | 2.67 | 8.69 |
| Standard deviation | 0.05 | 0.12 | 0.28 | 0.05 | 0.13 | 0.33 |
| CV(%) | 5.5 | 4.84 | 3.24 | 5.99 | 4.92 | 3.83 |
RECOVERY
The recovery of Human DCT spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 85-97 | 91 |
| EDTA plasma (n=8) | 89-102 | 97 |
| Cell culture media (n=8) | 88-101 | 95 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human DCT in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with DT ELISA Kits
| TYRP1 ELISA Kit | publications with DT and TYRP1 |
| MITF ELISA Kit | publications with DT and MITF |
| SILV ELISA Kit | publications with DT and SILV |
| MLANA ELISA Kit | publications with DT and MLANA |
| OTX2 ELISA Kit | publications with DT and OTX2 |
| SOX9 ELISA Kit | publications with DT and SOX9 |
Pathways associated with DT ELISA Kit
| Melanogenesis Pathway | Melanogenesis Pathway |
| Neural Crest Differentiation Pathway | Neural Crest Differentiation Pathway |
| Tyrosine Metabolism Pathway | Tyrosine Metabolism Pathway |
Diseases associated with DT ELISA Kit
| Neoplasms | publications with DT and Neoplasms |
| Hypertension | publications with DT and Hypertension |
| Kidney Diseases | publications with DT and Kidney Diseases |
| Carcinoma | publications with DT and Carcinoma |
| Heart Diseases | publications with DT and Heart Diseases |
| Drug Toxicity | publications with DT and Drug Toxicity |
| Neoplasms, Experimental | publications with DT and Neoplasms, Experimental |
| Adenocarcinoma | publications with DT and Adenocarcinoma |
| Lung Neoplasms | publications with DT and Lung Neoplasms |
| Necrosis | publications with DT and Necrosis |
Organs/Tissues associated with DT ELISA Kit
| Kidney | publications with DT and Kidney |
| Eye | publications with DT and Eye |
| Skin | publications with DT and Skin |
| Heart | publications with DT and Heart |
| Brain | publications with DT and Brain |
| Bone | publications with DT and Bone |
| Lung | publications with DT and Lung |
| Embryonic Tissue | publications with DT and Embryonic Tissue |
| Intestine | publications with DT and Intestine |
| Connective Tissue | publications with DT and Connective Tissue |